Concepedia

Vanessa Morales-Tirado

VM

Statistics

Publications

17

Citations

704

H-Index

13

Active since

2004

Affiliations

University of Tennessee Health Science Center(Current)

St. Jude Children's Research Hospital

AbbVie (United States)

Emory University

Wayne State University

Vanessa Morales-Tirado is an author at University of Tennessee Health Science Center specializing in life sciences, immunology, and oncology.

Publications per year

2004–2024

17

Publications

17

Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma

Anderson Hudgens Webb, Bradley T Gao, Zachary K. Goldsmith et al. · BMC Cancer · 2017 · 279 citations · Full text

, , +17

Cutting Edge: Selective Requirement for the Wiskott-Aldrich Syndrome Protein in Cytokine, but Not Chemokine, Secretion by CD4+ T Cells

Vanessa Morales-Tirado, Sara Johannson, Elaine Hanson et al. · The Journal of Immunology · 2004 · 63 citations · Full text

, , +17

The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism

Hua Yang, Craig M. Brackett, Vanessa Morales-Tirado et al. · Oncotarget · 2015 · 46 citations · Full text

, , +15

1α,25-dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3

Vanessa Morales-Tirado, David Wichlan, Thasia Leimig et al. · Clinical Immunology · 2010 · 43 citations · Full text

, , +17

Multipronged approach to identify and validate a novel upstream regulator of <i>Sncg</i> in mouse retinal ganglion cells

Sumana R. Chintalapudi, Vanessa Morales-Tirado, Robert W. Williams et al. · FEBS Journal · 2015 · 39 citations · Full text

, , +17

1–5 of 17